Sigma Healthcare's New Bull Expects Profit Margins to Widen -- Market Talk

Dow Jones03-20 06:06

2206 GMT - Sigma Healthcare's share price recently dropped to a more than one-year low, leading Jefferies to turn bullish on the pharmacy owner's stock. Analyst David Stanton says Sigma is a high-quality retail franchise. "We expect growth to continue, notwithstanding moderating impact from GLP-1 sales in 2H FY26," Jefferies says. It expects Sigma's profit margins to expand more. That's due to increased volumes off a fixed-cost base and ongoing growth in higher-margin generic drugs. Jefferies also expects Sigma to make improvements in its wholesaling business. It upgrades Sigma to buy, from hold. Sigma ended Thursday at A$2.66, below Jefferies's A$3.05/share price target. (david.winning@wsj.com; @dwinningWSJ)

(END) Dow Jones Newswires

March 19, 2026 18:06 ET (22:06 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2620264274?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-20 06:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2620264274","market":"nz","top_or_hot":-1,"title":"Sigma Healthcare's New Bull Expects Profit Margins to Widen -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     2206 GMT - <a href=\"https://laohu8.com/S/SIGGF\">Sigma Healthcare</a>'s share price recently dropped to a more than one-year low, leading Jefferies to turn bullish on the pharmacy owner's stock. Analyst David Stanton says Sigma is a high-quality retail franchise. \"We expect growth to continue, notwithstanding moderating impact from GLP-1 sales in 2H FY26,\" Jefferies says. It expects Sigma's profit margins to expand more. That's due to increased volumes off a fixed-cost base and ongoing growth in higher-margin generic drugs. Jefferies also expects Sigma to make improvements in its wholesaling business. It upgrades Sigma to buy, from hold. Sigma ended Thursday at A$2.66, below Jefferies's A$3.05/share price target. (david.winning@wsj.com; @dwinningWSJ) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 19, 2026 18:06 ET (22:06 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sigma Healthcare's New Bull Expects Profit Margins to Widen -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSigma Healthcare's New Bull Expects Profit Margins to Widen -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-03-20 06:06</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     2206 GMT - <a href=\"https://laohu8.com/S/SIGGF\">Sigma Healthcare</a>'s share price recently dropped to a more than one-year low, leading Jefferies to turn bullish on the pharmacy owner's stock. Analyst David Stanton says Sigma is a high-quality retail franchise. \"We expect growth to continue, notwithstanding moderating impact from GLP-1 sales in 2H FY26,\" Jefferies says. It expects Sigma's profit margins to expand more. That's due to increased volumes off a fixed-cost base and ongoing growth in higher-margin generic drugs. Jefferies also expects Sigma to make improvements in its wholesaling business. It upgrades Sigma to buy, from hold. Sigma ended Thursday at A$2.66, below Jefferies's A$3.05/share price target. (david.winning@wsj.com; @dwinningWSJ) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 19, 2026 18:06 ET (22:06 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4585","symbol_name":"ETF&股票定投概念","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2620264274","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2620264274","pubTimestamp":1773957960,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"2206 GMT - Sigma Healthcare's share price recently dropped to a more than one-year low, leading Jefferies to turn bullish on the pharmacy owner's stock. Analyst David Stanton says Sigma is a high-quality retail franchise. \"We expect growth to continue, notwithstanding moderating impact from GLP-1 sales in 2H FY26,\" Jefferies says. It expects Sigma's profit margins to expand more. That's due to increased volumes off a fixed-cost base and ongoing growth in higher-margin generic drugs. Jefferies also expects Sigma to make improvements in its wholesaling business. It upgrades Sigma to buy, from hold. Sigma ended Thursday at A$2.66, below Jefferies's A$3.05/share price target. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4585":"ETF&股票定投概念","SIG.AU":"SIGMA HEALTHCARE LTD","LABU":"三倍做多标普生物-Direxion","BK4581":"高盛持仓","LU0128526141.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" ACC","XBI":"SPDR S&P Biotech ETF","HCSG":"Healthcare Svcs Group Inc","LU0029874061.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" YDIS INC","BK7103":"保健护理产品经销商","XLV":"健康照护类股ETF-SPDR","BK4137":"综合支持服务","BK4588":"碎股"},"translate_title":"Sigma Healthcare的新牛市预计利润率将扩大——市场讨论","themeId":"8603dabb40994e59ac78c04c930c0d49","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SIG.AU":0.9,"HCSG":1.5,"XBI":0.6,"XLV":1.5,"LABU":0.6},"content_text":"2206 GMT - Sigma Healthcare's share price recently dropped to a more than one-year low, leading Jefferies to turn bullish on the pharmacy owner's stock. Analyst David Stanton says Sigma is a high-quality retail franchise. \"We expect growth to continue, notwithstanding moderating impact from GLP-1 sales in 2H FY26,\" Jefferies says. It expects Sigma's profit margins to expand more. That's due to increased volumes off a fixed-cost base and ongoing growth in higher-margin generic drugs. Jefferies also expects Sigma to make improvements in its wholesaling business. It upgrades Sigma to buy, from hold. Sigma ended Thursday at A$2.66, below Jefferies's A$3.05/share price target. (david.winning@wsj.com; @dwinningWSJ) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 19, 2026 18:06 ET (22:06 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.37.0","shortVersion":"4.37.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2620264274","isCrawlerRequest":true}